We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRVI icon
4676
Trevi Therapeutics
TRVI
$2.54B
$7K ﹤0.01%
4,803
+616
+15% +$1.09K
UAVS icon
4677
AgEagle Aerial Systems
UAVS
$58.3M
$7K ﹤0.01%
2
-4
-67% -$14.9K
UGL icon
4678
ProShares Ultra Gold
UGL
$801M
$7K ﹤0.01%
500
– –
URTY icon
4679
ProShares UltraPro Russell2000
URTY
$354M
$7K ﹤0.01%
68
-32,481
-100% -$3.37M
YARW
4680
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
$7K ﹤0.01%
6
+2
+50% +$3.88K
WNW icon
4681
Meiwu Technology Co
WNW
$76.6M
– –
0
– –
XELB icon
4682
Xcel Brands
XELB
$5.77M
$7K ﹤0.01%
451
+184
+69% +$3.73K
XFOR icon
4683
X4 Pharmaceuticals
XFOR
$424M
$7K ﹤0.01%
42
-399
-90% -$65.6K
GRDX
4684
GridAI Technologies Corp
GRDX
$22.3M
– –
0
– –
ORKA
4685
Oruka Therapeutics
ORKA
$6.93B
$7K ﹤0.01%
195
+189
+3,150% +$6.99K
FNGA
4686
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
$7K ﹤0.01%
20
-9
-31% -$3.29K
PYCR
4687
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$7K ﹤0.01%
+213
New +$6.99K
OMGA
4688
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$7K ﹤0.01%
+380
New +$7.29K
VIRX
4689
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$7K ﹤0.01%
927
+286
+45% +$2.82K
THCPU
4690
DELISTED
Thunder Bridge Capital Partners IV, Inc. Unit
THCPU
$7K ﹤0.01%
+756
New +$7.48K
ALIM
4691
DELISTED
Alimera Sciences
ALIM
$7K ﹤0.01%
1,491
+542
+57% +$3.78K
SDPI
4692
DELISTED
Superior Drilling Products Inc.
SDPI
$7K ﹤0.01%
+3,745
New +$3K
AONC
4693
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$7K ﹤0.01%
713
+613
+613% +$5.94K
LICY
4694
DELISTED
Li-Cycle Holdings Corp.
LICY
$7K ﹤0.01%
+73
New +$5.38K
CMLS
4695
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$7K ﹤0.01%
563
+522
+1,273% +$6.29K
BNKD
4696
DELISTED
MicroSectorsTM U.S. Big Banks Index -3X Inverse Leveraged ETNs
BNKD
$7K ﹤0.01%
+119
New +$7.67K
ROSS.U
4697
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$7K ﹤0.01%
+688
New +$6.88K
CYT
4698
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$7K ﹤0.01%
+397
New +$7.42K
LCAHU
4699
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$7K ﹤0.01%
693
+660
+2,000% +$6.58K
BPTH
4700
DELISTED
Bio-Path Holdings Inc
BPTH
$7K ﹤0.01%
70
+60
+600% +$7.2K
186 187
188
189 190

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.